SEC Comment Letter for BioCardia, Inc. (BCDA) (CIK 0000925741) (BCDA) — Apr 17, 2019
BioCardia, Inc. (BCDA) (CIK 0000925741)
Date: April 17, 2019 · CIK: 0000925741 · Accession: 0000000000-19-007267
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230779
Letter
April 17, 2019 Peter Altman, Ph.D. President and Chief Executive Officer BioCardia, Inc. 125 Shoreway Road, Suite B San Carlos, CA 94070 Re:BioCardia, Inc. Registration Statement on Form S-1 Filed April 9, 2019 File No. 333-230779 Dear Dr. Altman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Nathan Robinson, Esq.
Show Raw Text
April 17, 2019
Peter Altman, Ph.D.
President and Chief Executive Officer
BioCardia, Inc.
125 Shoreway Road, Suite B
San Carlos, CA 94070
Re:BioCardia, Inc.
Registration Statement on Form S-1
Filed April 9, 2019
File No. 333-230779
Dear Dr. Altman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Nathan Robinson, Esq.